Blocking glutamine metabolism with the glutaminase inhibitor CB-839 significantly impaired glutathione production in multiple AML cell lines, leading to the accumulation of mitochondrial ROS and apoptosis (73, 74). This evidence concerns the gene GLS and acute myeloid leukemia.